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Abstract:  
Background and aims: Recurrent pancreatitis is a severe complication of Familial 
Chylomicronemia Syndrome (FCS) mainly secondary to lipoprotein lipase deficiency. 
The mechanism and interindividual variability of pancreatitis in FCS is not fully 
understood, but abnormalities in the drainage system of pancreatic veins could be 
involved.  
Methods and results: Two cases of typical FCS are described with a past history of 
recurrent pancreatitis that dramatically improved after splenectomy performed in both 
cases for reasons non-related to FCS.  
Conclusion: These are the first reports of the disappearance of pancreatitis after 
splenectomy in FCS and they should be considered of anecdotal nature at this time. The 
disappearance of pancreatitis following splenectomy could be in part due to subsequent 
improvements in pancreatic drainage. Extrahepatic portal hypertension induced by 
hypertriglyceridemic splenomegaly leading to pancreatic congestion could also be a 
contributing factor. 
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Introduction 
Familial Chylomicronemia Syndrome (FCS) deficiency is a rare autosomal 
recessive disorder characterized by the absence or the severe reduction of lipoprotein 
lipase (LPL) activity and a massive accumulation of chylomicrons in plasma leading to 
a large increase of plasma triglyceride concentration, usually greater than 22.5 mmol/L 
(2000 mg/dl) in the fasting state (1). FCS is clinically characterized by repeated 
abdominal pain episodes, recurrent acute pancreatitis, eruptive cutaneous 
xanthomatosis, lipemia retinalis and hepatosplenomegaly. FCS is mostly identified in 
childhood due to recurrent episodes of pancreatitis and high fasting triglycerides (2). 
Pancreatitis is the most serious complication of LPL deficiency. The underlying 
pathophysiological mechanisms are not fully understood (3). FCS is a very rare disease 
with a frequency at about one per million in the general population, although it may be 
higher in some populations due to a founder effect (4).  
The degree of hyperchylomicronemia in FCS depends, at least in part, on dietary 
fat intake, but genetic heterogeneity can play a role (5). It has been observed that a 
severe restriction of dietary fat to less than 20 g/day is enough to control the symptoms 
in some cases (6). In contrast, FCS is usually not responsive to conventional lipid-
lowering therapy. Acute pancreatitis characterizes early stages of the disease while 
some patients may develop recurrent abdominal pain and chronic pancreatitis as the 
disease progresses. Hepatomegaly and splenomegaly could appear over time when the 
chylomicronemia becomes chronic. Splenomegaly is less frequently observed than 
hepatomegaly and can be notably hard. The organomegaly occurs as result of 
triglyceride uptake by macrophages. These individuals might show anemia and/or 
thrombocytopenia due to secondary hypersplenism (1,7). 
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In this study we describe two unrelated cases of typical FCS with a past history 
of recurrent pancreatitis controlled in two different lipid clinics in Spain. Both cases 
have shown a dramatic improvement in pancreatitis after a splenectomy was performed 
due to reasons non-related to FCS. 
 
Material and methods 
Lipoprotein Activity. The LPL activity assay was done on post-heparin samples on an 
Intralipid 10% emulsion as previously described (8).  Each sample for LPL activity was 
assayed in triplicate and two standard samples were analyzed in each assay.  
Genetic analysis. DNA was extracted by standard methods. Promoters, coding regions 
and intron-exon boundaries of LPL, APOA5, APOC2, and GPIHBP1 were amplified by 
PCR and purified by ExoSap-IT (USB) using primers previously described (9). 
Amplified fragments were sequenced by Sanger method using the BigDye 3.1 
sequencing kit (Applied Biosystems) in an automated ABI 3500xL sequencer (Applied 
Biosystems). 
 
Results  
The first case is a 68-year-old man who first visited our Lipid Unit at the 
Hospital Universitario Miguel Servet, Zaragoza, Spain, approximately 20 years ago. He 
was referred by his physician for the study of severe hypertriglyceridemia (HTG) with 
fasting plasma concentrations between 22.5-45 mmol/l (2000-4000 mg/dl from, at least, 
the age of 30 years old. At his first visit the patient was asymptomatic and the physical 
exam was normal except for low weight and body mass index (61.4 Kg and 18 kg/m², 
respectively). He was following a low-fat diet and his fasting lipid profile showed 
triglycerides 39.2 mmol/l (3473 mg/dl); total cholesterol 7.8 mmol/l (303 mg/dl); HDL 
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cholesterol 0.62 mmol/l (24 mg/dl), apolipoprotein B (apoB) 90 mg/dl, and plasma 
Lp(a) 3.56 mg/dl. Other biochemical parameters including thyroid hormones, glucose, 
liver enzymes, and creatinine were in the normal range. His post-heparin lipoprotein 
lipase activity was undetectable in two occasions (<10 µU/ml, normal values 22-47.6 
µU/ml). Years later, the sequencing analysis of LPL, APOC2, APOA5, LMF1 and 
GPIHBP1 showed that the patient was double heterozygous with a pathogenic mutation 
in LPL gene (p.Pro234Leu) and two different pathogenic mutations in LMF1 
(p.Arg354Trp) and (p.Arg364Gln) (9). He was diagnosed of FCS secondary to LPL 
deficiency. He has been reviewed periodically in our unit, remaining asymptomatic and 
without substantial changes in his physical exam or lipid phenotype. 
He began at the age of 22 with recurrent episodes of abdominal pain. These 
episodes repeated once or twice a year, lasting 4-12 hours, ceasing after prolonged 
fasting. At the age of 28, the patient was admitted to our hospital because of another 
episode of diffuse abdominal pain, more intense and prolonged than previous, with 
maximal pain in the upper left quadrant of the abdomen. His physical exam was normal 
except for mild splenomegaly. He was treated with fasting, analgesia and intravenous 
fluids and the pain resolved within a few hours. Triglycerides and pancreatic enzymes 
were not analyzed during his hospital stay. However, mild leukocytosis and lipemic 
plasma was observed at admission. He was discharged with the diagnosis of abdominal 
pain secondary to splenomegaly.  
At the age of 31 years and following a parachuting accident, he began to 
experience severe abdominal pain and underwent emergency splenectomy in another 
center under the suspicion of a spleen rupture. The pathological study of the spleen was 
not performed. After the splenectomy, the pain disappeared and he has remained 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
asymptomatic ever since. His current lipid profile shows: triglycerides 31.0 mmol/l 
(2748 mg/dl); total cholesterol 10.9 mmol/l (423 mg/dl); and apo B 82.6 mg/dl. 
 
Second case presentation 
A 43 year old woman was reviewed at the Lipid Unit, Hospital Universitario 
Gregorio Marañon in Madrid, Spain, where she was diagnosed with FCS due to severe 
HTG from birth, recurrent episodes of acute pancreatitis and very low post-heparin LPL 
activity: 5.2 µU/ml. Sequencing analysis of the LPL gene showed that the patient was 
homozygous for a functional LPL mutation (G188E/G188E). Her parents had a pattern 
of mild combined hyperlipidemia and were heterozygous to G188E mutation in LPL.  
The patient started suffering from abdominal pain at 2 months of age, with 
triglycerides above 22.5 mmol/l (2000 mg/dl) in several controls. Breast-feeding was 
stopped and she started receiving an artificial milk formula.  
Along her infancy she experienced several episodes of abdominal pain. No 
registries of clear pancreatitis were reported up to the age of 13 years. In analytical 
controls she always had chylomicronemia with values of triglycerides higher than 22.5 
mmol/l (2000 mg/dl). In two reports at the age of 12 and 13 she presented eruptive 
xanthomas in the shoulders, neck and thorax. At least six cases of acute pancreatitis 
were documented between the ages of 13-26. Additionally, she reported frequent 
episodes of mild to moderate abdominal pain. 
She became pregnant at 26 years old and suffered a mild pancreatitis after 4 
months of pregnancy. During her 5th month of pregnancy she reported severe 
pancreatitis and developed a pseudocyst and later a pancreatic abscess. An elective 
cesarean was performed during her 25th week of pregnancy. The child who is nowadays 
alive and healthy (no lipids data are available). Image studies following the caesarean 
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showed multiple gallstones. Part of the body and tail of the pancreas had disappeared 
due to autodigestion following the last severe pancreatic episode. Ten months after the 
caesarean, an elective surgery was done due to mechanical small bowel obstruction 
secondary to abdominal adhesions. Y Roux gastro-jejunostomy, cholecystectomy and 
splenectomy were performed. Splenectomy was due to suspected spleen vein 
thrombosis in presence of splenomegaly and spleen congestion. The spleen was well 
encapsulated, 15 cm long and 500 g weight. Histopathologically, the capsule was 
thickened; red pulp was predominant, there was endothelial hyperplasia, enlargement of 
the splenic sinuses, and fibrosis of intersinusal spaces. Penicilliary arterioles showed 
marked sclerosis. Lipid-laded macrophages were not observed. The pathological 
diagnosis was chronic congestive splenomegaly (Figure). Few months later she was 
admitted in the hospital due to mild episodes of pancreatitis twice (the last one not 
clearly confirmed). Since then, 11 years later, the patient has had no further pancreatitis 
episodes in spite of chylomicronemia with high triglycerides values 29.6 mmol/l (2629 
mg/dl) found on Oct 29th, 2015 and 37.4 mmol/l (3316 mg/dl) on Dec 18th, 2015). 
 
Discussion  
The two cases presented in this report illustrates the disappearance of abdominal 
pain after performing a splenectomy in patients with FCS. It is the first description in 
the literature of this favorable evolution in this disease and thus generates hypotheses 
that can help to identify some of the mechanisms associated with the onset of 
pancreatitis and chronic pain in these patients. 
Abdominal pain is very common in FCS and is due in most cases to episodes of 
recurrent acute pancreatitis or subsequent complications (10). Approximately 50% of 
subjects with FCS have at least one episode of severe pancreatitis (11). Alcohol 
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consumption, pregnancy and poor compliance with a low-fat diet are risk factors for the 
development of pancreatitis in FCS; however, even in absence of these factors, 
pancreatitis may develop with large differences among subjects, even those sharing the 
same pathogenic mutation (11). Recently, two loci: the chymotrypsinogen C (CTRC) 
and serine protease inhibitor Kazal-type1 (SPINK1) have been associated with a risk of 
recurrent hospitalization for acute pancreatitis in severe HTG due to FCS (17). 
However, these genes are poorly studied and their plausible association with 
pancreatitis is not related to pancreatic secretion or drainage, or to spleen function. 
Furthermore, the improvement of pancreatic episodes after splenectomy in our cases 
does not support a genetic predisposition to pancreatitis in our patients (12).  
In the two cases reported here, episodes of recurrent pancreatitis seem evident 
given the characteristics of the episodes of pain and the confirmation of LPL deficiency. 
However, because the first case happened 40 years ago, it is difficult to verify at present 
time regardless of the episodes very suggestive nature. 
The mechanism by which very severe HTG leads to pancreatitis has not been 
fully elucidated, but it is likely related to the liberation by pancreatic lipase of free fatty 
acids (FFA) from triglycerides and lysophosphatidylcholine from phosphatidycholine, 
when the pancreas is exposed to severe hyperchylomicronemia in the pancreatic 
capillaries (7). High local concentrations of FFA overwhelm the binding capacity of 
albumin with resultant aggregation into micellar structures with detergent properties 
(13).  
The association of chronic pancreatitis with splenomegaly has been well-
documented for some time (14). On the one hand, splenomegaly and pancreatitis are 
more frequent in the presence of very high triglyceride levels, so they could be 
concomitant manifestations in nature without having a causal association between them. 
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Splenomegaly can also be the result of complications from pancreatitis such as 
pseudocysts, abscesses, infarcts, hemorrhages or vascular lesions causing splenic portal 
hypertension (15). However, the association between splenomegaly and pancreatitis 
appears even in the absence of HTG and sometimes precedes the development of 
pancreatitis in the presence of splenic venous thrombosis, and so other mechanisms may 
be involved. As pointed out by Francesco and cols (16), it is difficult to establish which 
came first, the pancreatitis or the splenomegaly, what they call the chicken or the egg 
causality dilemma. 
The most plausible explanation for the disappearance of episodes of pancreatitis 
in the exposed cases would be a hemodynamic mechanism. The pancreatic veins drain 
into the splenic vein and the latter into the vena cava. Splenomegaly frequently 
associates extrahepatic portal hypertension that hinders pancreatic drainage (17). In a 
retrospective analysis, Ramesh et al reported the effect of different surgical techniques 
to get pain relief in patients with chronic pancreatitis and signs of portal hypertension. 
In their work, 15 out of 57 patients had chronic pancreatitis with extrahepatic portal 
hypertension secondary to thrombosis of the splenic vein, and in these cases, 
splenectomy was performed along with pancreatic drainage. The authors observed that 
the surgery significantly improved the symptoms of these patients (18). It would be 
possible that in the presence of defective pancreatic venous drainage increased FFA 
accumulation and pancreatic aggression may occur. Splenectomy improves pancreatic 
venous drainage and could favor the decrease of pancreatitis in certain cases of 
hypertriglyceridemic pancreatitis associated with extra hepatic portal hypertension. It 
would be interesting to know if there are more cases of hypertriglyceridemic 
pancreatitis and splenectomy worldwide, in order to further confirm our observation.  
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These two observations cannot induce one to perform splenectomy in FCS 
patients with recurrent pancreatitis. They should be considered of anecdotal nature and 
without cause-and-effect relationship between splenectomy and recurrent pancreatitis. 
This association would require a definite demonstration of the deleterious effect of 
elevated extrahepatic portal pressure in FCS subjects. Furthermore, the effect of 
splenectomy in FCS animal models (19,20) should be profoundly studied before any 
human intervention study should commence. 
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Figure legend 
Histopathological findings of the spleen of the case 2 stained with hematoxylin and 
eosin. A (x 100) and B (x 400). Red pulp is predominant. Endothelial hyperplasia, 
enlargement of the splenic sinuses, and brown areas indicating hemosiderin deposits 
(arrows) are present. The pathological diagnosis was chronic congestive splenomegaly. 
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- Pancreatitis is a frequent and serious complication in familial 
chylomicronemia 
- We present two cases in which recurrent pancreatitis disappeared after 
splenectomy 
- Extrahepatic portal hypertension favors the development of pancreatitis 
- Improvement of portal drainage could explain this favorable evolution 
